Gradalis

Investors · 2

WP

WP Global PartnersChicago · $5M – $25M

WP

WP ExplorerreportedChicago

GE

Genialis12 shared keywordsGenialis develops artificial intelligence models trained on ethnically diverse cancer datasets to predict patient responses to targeted therapies and immunotherapies, supporting treatment decisions for pharmaceutical and diagnostic companies.

AL

Alumis10 shared keywordsAlumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted oral therapies for immune-mediated diseases such as plaque psoriasis. Its precision drug-development approach is supported by a proprietary data analytics platform.

ZE

Zentailis10 shared keywords

PA

Parabilis Medicines9 shared keywordsHelicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules. The platform uses AI and simulation to engineer helical peptides with non-canonical amino acids for precision binding across a range of therapeutic applications.

PA

PatSnap9 shared keywordsPatsnap builds an AI-powered platform for R&D, IP, and innovation intelligence, offering tools for patent search, novelty and FTO analysis, patent drafting, and materials and pharma research. It serves R&D leaders, IP professionals, engineers, and scientists across industries including materials, manufacturing, life sciences, pharmaceuticals, and consumer goods.

PR

Prellisbio9 shared keywordsPrellis develops an AI-enabled platform for antibody discovery using 3D-printed organoids that recapture human immune biology, generating therapeutic antibody candidates for multiple disease areas. The platform combines machine learning with wet lab characterization to accelerate the development of fully human antibody therapeutics.

CO

Cowles_Investments_StemCentrx8 shared keywordsFierce Biotech is a news publication covering the biotechnology, pharmaceutical, and medtech industries, reporting on clinical trials, deals, venture capital, drug development, and research. It serves industry professionals through articles, special reports, events, webinars, and podcasts.

GR

GRAIL7 shared keywordsGRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear. The test is offered by prescription in the United States and through partnerships with healthcare systems, insurance carriers, and diagnostic platforms.

EX

Exelixis7 shared keywords

Companies competing with Gradalis for the same Google search keywords, organic and paid, via search-intersection analysis.

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.